reports
Mesa Air Group Reports First Quarter Fiscal 2024 Results
Mesa Air Group Reports First Quarter Fiscal 2024 Results PHOENIX, May 20, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2024 financial and operating results. First Quarter Fiscal 2024 Update: Total operating revenues of $118.8 millionPre-tax loss of $57.0 million, net loss of $57.9 million or $(1.41) per diluted shareAdjusted net loss1 of $21.8 million2 or $(0.53) per diluted shareAdjusted EBITDAR1 of $6.3 millionBlock hours of 46,658, an approximate 5% increase over fourth quarter fiscal 2023Paid down $39.2 mi...
Nicole Robinson Appointed President of DataPath Inc.
Nicole Robinson Appointed President of DataPath Inc. David McDonald will transition to the role of Vice Chairman of DataPath Board of Directors. PETAH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that Nicole Robinson has been appointed as President of DataPath. Ms. Robinson is an international satellite industry executive with a proven record in driving growth, managing global sales and operational teams, and deploying next-gen...
Ocugen Announces CSO to Present on Modifier Gene Therapy at Internatio...
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024 MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun Upadhyay, PhD, Chief Scientific Officer, Head of Research & Development, Ocugen will speak at the International Society for Cell & Gene Therapy (ISCT) Annual Meeting being held May 29-June 1, 2024 in Vancouver, Canada. ...
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit ...
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on Tuesday, June 4, 2024, and the Jefferies Global Healthcare Conference in New York on Wednesday, June 5, 2024. Management will host 1x1 investor meetings at the UBS Healthcare Services Summit on June 4, 2024. For the Jefferies Global Healthcare Conference on June 5...
Perspective Therapeutics to Present at the Society of Nuclear Medicine...
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024 SEATTLE, May 20, 2024 (GLOBE NEWSWIRE) -- (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced the Company will present information pertaining to the Company’s sponsored studies of its assets at the Society of Nuclear Medicine & Molecular Imaging (“SNMMI”) Annual Meeting 2024, which is being held in Toronto, Canada, from June 8-11, 2024. ...
ECARX Announces First Quarter 2024 Unaudited Financial Results
ECARX Announces First Quarter 2024 Unaudited Financial Results Exhibit 99.1 SHANGHAI, China, May 20, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended March 31, 2024. “The strong growth momentum that we picked up last year continued into the first quarter with revenues increasing 21% year-over-year,” commented ECARX Chairman and CEO Ziyu Shen. “The development of software-defined vehicles and their underpinning technologies will determine the wi...
Global-e Reports First Quarter 2024 Results
Global-e Reports First Quarter 2024 Results PETAH-TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, today reported its financial results for the first quarter of 2024. “The strong results of our first quarter of 2024, which we are reporting today, mark a great start for what we believe is set out to be another pivotal year for Global-e,” said Amir Schlachet, Founder and CEO of Global-e. “With numerous client adds and business expansion across a...
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Univer...
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing FORT WORTH, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that, in collaboration with Cleveland Clinic, the Company is advancing multiple multivalent universal influenza vaccines to protect against...
Arqit Quantum Inc. Announces Financial and Operational Results for the...
Arqit Quantum Inc. Announces Financial and Operational Results for the First Half of Fiscal Year 2024 $119,000 of revenue for the six month period ended 31 March 2024 with certain prospective deals slipping to the second half of the fiscal year Renewal or contract extension with nine existing customers, representing revenue from small engagements with potential for larger revenue opportunities in the future Recent significant award notification Additional cost reduction initiative commenced, which is expected to reduce operating costs to $1.8 million per month Cash position of $21.3 m...
Entero Therapeutics Presents Two Posters on Celiac Disease Research at...
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference Presentations highlight new VCIEL scale to measure small intestinal mucosal health and research from rich database of latiglutenase Phase 2 clinical trials BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, yesterday presented two posters on...
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corp...
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened, is ongoing. Sol-Gel and Beimei Pharma announced an Asset Purchase Agreement to commercialize TWYNEO® in China, Hong Kong, Macau, Taiwan and Israel, for a total consideration of up to $115 million.Sol-Gel recently initiated a proof-of-concept study for SGT-210 (topical erlotinib) in patients with Darier disease.Highly encouraging clinical response for SGT-210 from a Compassionate use treatment for a pediatric patient suffer...
Vivid Seats to Participate in William Blair’s 2024 Growth Stock Confer...
Vivid Seats to Participate in William Blair’s 2024 Growth Stock Conference CHICAGO, May 20, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced that Stan Chia, Chief Executive Officer, and Lawrence Fey, Chief Financial Officer, will be presenting at William Blair’s 2024 Growth Stock Conference on Wednesday, June 5, 2024 at 8:40 a.m. CT. A live webcast of the presentation will be a...
Sono-Tek Announces Year-End FY 2024 Earnings Conference Call
Sono-Tek Announces Year-End FY 2024 Earnings Conference Call Conference Call on Thursday, May 23, 2024 at 9:30 am ET MILTON, N.Y., May 20, 2024 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its year-end fiscal year 2024 financial results, ended February 29, 2024, on Thursday, May 23, 2024 at 9:30 am ET. The year-end FY 2024 financial results press release will be issued before the market opens on May 23, 2024. Conference Call Dial-...
Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Inv...
Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Investor Conferences TEL AVIV, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT, TASE: ENLT), a leading global renewable energy platform, today announced the Company will participate in two upcoming investor conferences. JP Morgan Energy, Power and Renewables Conference, Monday, June 17, 2024, in New York CityRoth MKM London Conference, Wednesday, June 26, 2024, in London Management will be available for one-on-one and small group meetings with institutional investors du...
Highest Performances Holdings Inc. (NASDAQ: HPH) to Announce Unaudited...
Highest Performances Holdings Inc. (NASDAQ: HPH) to Announce Unaudited Financial Results For The First Half of The Fiscal Year 2024 and Host Conference Call on May 30, 2024 GUANGZHOU, China, May 20, 2024 (GLOBE NEWSWIRE) -- Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), today announced that it will release its unaudited financial results for the first half of its fiscal year 2024 ended December 31, 2023 on May 30, 2024. Senior management of the Company will host a bilingual conference call in English and Chinese to discuss the Company’s unaudited financial r...
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate ...
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale New production process will be developed based on Pluri’s proprietary 3D cell expansion technologyHuman breast milk oligosaccharides are known to shape the gut microbiota and thus provide to adultsGlobal elderly nutrition market is $39.7 billion in less than 10 years HAIFA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Leading biotechnology company Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), which transforms cells into soluti...
Edison issues review on BB Biotech (BION): A recovering sector with a ...
Edison Investment Research Limited Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis 20-May-2024 / 11:53 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 20 May 2024 Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech assets that target substantial market opport...
Aesthetic Medical International Holdings Group Ltd. Announces Receipt ...
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel SHENZHEN, China, May 20, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it has received a determination letter of the Hearings Panel (the “Panel”) of The Nasdaq Capital Market (“Nasdaq”) dated May 17, 2024, notifying the Company that the Panel determined to delist the Company’s securities from Nasdaq, due to the failu...
Expro Celebrates Milestone Achievement With Completion of 100th Global...
HOUSTON--(BUSINESS WIRE)-- Expro (NYSE: XPRO), a leading provider of energy services, has successfully completed its 100th job globally of its field-proven cementing technology, SeaCure®, marking a significant milestone. This press release features multimedia. View the full release here: (L to R): Expro senior product line manager, Tristam Horn alongside chief operating officer, Alistair Geddes (Photo: Business Wire) The completion of this landmark project emphasizes Expro's commitment to delivering innovative solutions and exceptional service to its clients worldwide. The 100th SeaCure® jo...
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension BAUDETTE, Minn., May 20, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use. Kionex® Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS® Suspension for Oral or Rectal use. "The launch of Kionex® Suspension for Oral or Rectal use exemplifies our capability to bring complex generics with limited market competition to our custom...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.